JewishStatusOpen the app

FrontRow · Aug 6, 2026

FrontRow — photo status

CVS Health announced a collaboration with Eli Lilly as the company reported second-quarter net income of nearly $3 billion and raised its full-year outlook by a wide margin. CVS also lifted its full-year adjusted earnings guidance to between $7.90 and $8.10 per share, up from its previous range of $7.30 to $7.50 per share. Full-year revenue guidance rose to at least $414 billion from at least $405 billion, the company said. Through CVS Health’s connected care model, broader direct to consumer access to prescription drugs is easier to deliver. For GLP-1s, it’s simple for eligible patients to use our scheduler technology to connect with licensed clinicians 24 hours a day through MinuteClinic®, access GLP-1 medications through CVS Pharmacy®, receive personalized pharmacist support, and use digital tools to identify available savings options. No separate memberships, no mail-order-only access, and no fragmented handoffs. As part of this broader effort, CVS Health and Lilly are collaborating to help eligible Zepbound and Foundayo patients more easily access transparent pricing, inclusive of reimbursed and self-pay options, through the CVS Health app.

CVS Health announced a collaboration with Eli Lilly as the company reported second-quarter net income of nearly $3 billion and raised its full-year outlook by a wide margin. CVS also lifted its full-year adjusted earnings guidance to between $7.90 and $8.10 per share, up from its previous range of $7.30 to $7.50 per share. Full-year revenue guidance rose to at least $414 billion from at least $405 billion, the company said. Through CVS Health’s connected care model, broader direct to consumer access to prescription drugs is easier to deliver. For GLP-1s, it’s simple for eligible patients to use our scheduler technology to connect with licensed clinicians 24 hours a day through MinuteClinic®, access GLP-1 medications through CVS Pharmacy®, receive personalized pharmacist support, and use digital tools to identify available savings options. No separate memberships, no mail-order-only access, and no fragmented handoffs. As part of this broader effort, CVS Health and Lilly are collaborating to help eligible Zepbound and Foundayo patients more easily access transparent pricing, inclusive of reimbursed and self-pay options, through the CVS Health app.

Watch in the app All of FrontRow's statuses

More from FrontRow